Krystal Biotech (KRYS) Other Operating Expenses (2023 - 2026)

Krystal Biotech (KRYS) has 4 years of Other Operating Expenses data on file, last reported at $6.3 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 25.76% year-over-year to $6.3 million; the trailing twelve-month figure through Mar 2026 stood at $24.3 million (up 274.34% YoY), and the FY2023 full-year result was $100.0 million, changed N/A from the prior year.
• Other Operating Expenses fell to $6.3 million in Q1 2026, from $6.6 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $100.0 million in Q3 2023 to a low of -$22.6 million in Q1 2024.
• A 4-year average of $8.4 million and a median of $5.0 million in 2025 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses tumbled 51.93% in 2024 and jumped 137.73% in 2025, its largest moves.
• Tracing KRYS's Other Operating Expenses over 4 years: stood at $100.0 million in 2023, then plunged by 118.99% to -$19.0 million in 2024, then surged by 134.71% to $6.6 million in 2025, then fell by 4.08% to $6.3 million in 2026.
• Business Quant data shows KRYS's Other Operating Expenses at $6.3 million in Q1 2026, $6.6 million in Q4 2025, and $4.3 million in Q3 2025.